Direct Antiviral Agent Treatment of Chronic HCV Infection Results in Rapid Regression of Transient Elastography (Fibroscan®) and Validated Fibrosis Markers FIB-4 and APRI
Jacqueline Bachofner(University Hospital Zurich), Joachim C. Mertens(GastroZentrum Hirslanden Zürich), Beat Müllhaupt(University Hospital of Zurich), P Valli(University Hospital Zurich), Arne Kröger(University Hospital Zurich)
Cited by 0
Related Papers
Cholangiocarcinoma 2020: the next horizon in mechanisms and management
|Nature Reviews Gastroenterology & Hepatology|2020|2.5k
Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)
|Nature Reviews Gastroenterology & Hepatology|2016|1.4k
Prognosis of patients with hepatocellular carcinoma treated with immunotherapy – development and validation of the CRAFITY score
|Journal of Hepatology|2021|309